ClassID:

20251

A61K31/215 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

Recent Application in this class:
#601
20130274256
2013-10-17

NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS

#602
20130261186
2013-10-03

Methods of treating autism

#603
20130245231
2013-09-19

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

#604
20130237560
2013-09-12

NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS

#605
20130236545
2013-09-12

Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria

#606
20130230542
2013-09-05

ROS-activated compounds as selective anti-cancer therapeutics

#607
20130225682
2013-08-29

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

#608
20130225678
2013-08-29

Therapeutic compositions

#609
20130225677
2013-08-29

Therapeutic compositions

#610
20130225516
2013-08-29

Topical compositions comprising fipronil and permethrin and methods of use

#611
20130216606
2013-08-22

Liposomal formulation for ocular drug delivery

#612
20130203712
2013-08-08

Methods for inhibiting muscle atrophy

#613
20130165495
2013-06-27

Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors

#614
20130157990
2013-06-20

METHOD OF DRUG DETOXIFICATION

#615
20130156749
2013-06-20

Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger

#616
20130143961
2013-06-06

Anti-viral carbamimidothioic acid esters

#617
20130142890
2013-06-06

Composition and uses for influencing hair growth

#618
20130137766
2013-05-30

Compound Used to Prevent Diseases Caused by Aquaporin Deficiency

#619
20130131171
2013-05-23

Treatment for meibomian gland dysfunction or obstruction

#620
20130131088
2013-05-23

TREATING CANCER WITH STATINS AND COMPOUNDS HAVING DIPYRIDAMOLE ACTIVITY

#621
20130129842
2013-05-23

COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES

#622
20130116319
2013-05-09

Agent for treating Parkinson's disease

#623
20130115260
2013-05-09

ANTIMICROBIAL COMPOSITION

#624
20130109752
2013-05-02

Derivative of 18β-glycyrrhetinic acid apt to suppress cancer cells

#625
20130101686
2013-04-25

Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies

#626
20130101667
2013-04-25

Cyclohexylamines

#627
20130101553
2013-04-25

INDUCING INACTIVATION OF FIBROGENIC MYOFIBROBLASTS

#628
20130089615
2013-04-11

Compositions of jasmonate compounds

#629
20130085166
2013-04-04

Formulations and uses of retinoic acid receptor selective agonists

#630
20130079403
2013-03-28

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#631
20130079400
2013-03-28

Process for the preparation of pleuromutilins

#632
20130072694
2013-03-21

18β-Glycyrrhetinic acid derivatives and synthetic method thereof

#633
20130072561
2013-03-21

Methods for the treatment and prevention of age-related retinal dysfunction

#634
20130072560
2013-03-21

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#635
20130072559
2013-03-21

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#636
20130072557
2013-03-21

Methods for the treatment and prevention of age-related retinal dysfunction

#637
20130072556
2013-03-21

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#638
20130072555
2013-03-21

Methods for treating obesity or an obesity related condition

#639
20130065868
2013-03-14

ANXIOYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS

#640
20130065851
2013-03-14

Anti-viral formulations

#641
20130065846
2013-03-14

Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof

#642
20130064924
2013-03-14

NUTRITIONAL SUPPLEMENT FOR USE UNDER PHYSIOLOGICALLY STRESSFUL CONDITIONS

#643
20130052249
2013-02-28

ANTIMICROBIAL COMPOSITION

#644
20130045183
2013-02-21

Boswellia oil, its fractions and compositions for enhancing brain function

#645
20130045177
2013-02-21

Method for inhibition of potential-dependent cation channel

#646
20130040954
2013-02-14

PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES

#647
20130030050
2013-01-31

Treatment of osteoporosis

#648
20130029923
2013-01-31

Materials and Methods for Prevention and Treatment of Viral Infections

#649
20130023488
2013-01-24

Methods and compounds for reducing intracellular lipid storage

#650
20130023487
2013-01-24

Compounds and compositions for treating infection

#651
20130012587
2013-01-10

Methods of Treating Autism

#652
20130012586
2013-01-10

Methods of Treating Fragile X Syndrome

#653
20130012502
2013-01-10

Pharmaceutical or veterinary antiviral compositions

#654
20130005805
2013-01-03

Esters for treatment of ocular inflammatory conditions

#655
20130005804
2013-01-03

Novel Uses of Neuraminidase Inhibitors in Infectious Diseases

#656
20130005691
2013-01-03

Esters for treatment of ocular inflammatory conditions

#657
20120329757
2012-12-27

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#658
20120322756
2012-12-20

Metabolic imprinting effects of structured lipids

#659
20120321602
2012-12-20

Omega-3 fatty acid nutriceutical composition and optimization method

#660
20120315339
2012-12-13

Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

#661
20120315332
2012-12-13

PHARMACEUTICAL COMPOSITION INCLUDING SUNFLOWER EXTRACT, PREPARATIVE METHOD AND USE THEREOF

#662
20120315277
2012-12-13

Compositions and Methods for the Therapy and Diagnosis of Influenza

#663
20120309827
2012-12-06

Therapeutic compositions

#664
20120302635
2012-11-29

Water-swellable polymers

#665
20120302588
2012-11-29

Method of enhancing hair growth

#666
20120301432
2012-11-29

Boswellia low polar gum resin extract and its synergistic compositions

#667
20120295971
2012-11-22

Therapeutic compositions

#668
20120295970
2012-11-22

Therapeutic compositions

#669
20120288568
2012-11-15

METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION

#670
20120288485
2012-11-15

USE OF JASMONE FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND

#671
20120270933
2012-10-25

LIQUID STATIN FORMULATION

#672
20120270899
2012-10-25

Compositions and methods for treating cardiovascular diseases

#673
20120270845
2012-10-25

Compositions and methods for treating chronic inflammation and inflammatory diseases

#674
20120269777
2012-10-25

Compositions and soft tissue replacement methods

#675
20120253258
2012-10-04

Ocular system with anchoring implant and therapeutic agent

#676
20120252886
2012-10-04

CATECHINS FOR THE TREATMENT OF AMYLOIDOSIS

#677
20120245227
2012-09-27

Pharmaceutical compositions having desirable bioavailability

#678
20120245205
2012-09-27

COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH

#679
20120238632
2012-09-20

MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION

#680
20120225940
2012-09-06

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

#681
20120207738
2012-08-16

Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger

#682
20120196932
2012-08-02

Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism

#683
20120190739
2012-07-26

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

#684
20120190637
2012-07-26

COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS

#685
20120184614
2012-07-19

N-alkylcarbonyl-amino acid ester compounds and their use for cough and pharyngitis

#686
20120172325
2012-07-05

Methods and Compositions for the Treatment of Gastrointestinal Disorders

#687
20120149655
2012-06-14

Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate

#688
20120141578
2012-06-07

Compositions and methods relating to proliferative diseases

#689
20120129940
2012-05-24

Methods of treating autism

#690
20120129929
2012-05-24

COMPOUND USED TO PREVENT DISEASES CAUSED BY AQUAPORIN DEFICIENCY

#691
20120129926
2012-05-24

Calcium sensing receptor modulating compounds and pharmaceutical use thereof

#692
20120128754
2012-05-24

TREATMENT OF EYE DISCOMFORT BY TOPICAL ADMINISTRATION OF A COOLING AGENT TO THE EXTERNAL SURFACE OF THE EYELID

#693
20120122986
2012-05-17

Methods of treating fragile X syndrome

#694
20120107392
2012-05-03

Use of huperzine for disorders

#695
20120107385
2012-05-03

METHOD OF TREATING CONDITIONS ASSOCIATED WITH OVERACTIVE BLADDER

#696
20120083529
2012-04-05

USE OF JASMONATE ESTER DERIVATIVES FOR TREATING BENIGN HYPERPROLIFERATIVE SKIN DISORDERS

#697
20120071685
2012-03-22

Method for producing bicyclic γ-amino acid derivative

#698
20120071484
2012-03-22

Topical parasiticide composition

#699
20120071457
2012-03-22

Metallo-β-lactamase inhibitors

#700
20120065258
2012-03-15

STABLE PROSTAGLANDIN-CONTAINING COMPOSITIONS

#701
20120065179
2012-03-15

PRODRUG COMPRISING BETA-KETO CARBOXYLIC ACID, BETA-KETO CARBOXYLIC ACID SALT OR BETA-KETO CARBOXYLIC ACID ESTER FOR DRUG DELIVERY

#702
20120059057
2012-03-08

Antiviral treatments

#703
20120053152
2012-03-01

()-(-)-1,2-propanediol compositions and methods

#704
20120053141
2012-03-01

Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis

#705
20120039909
2012-02-16

EPIGENETIC MECHANISMS RE-ESTABLISH ACCESS TO LONG-TERM MEMORY AFTER NEURONAL LOSS

#706
20120034303
2012-02-09

Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix

#707
20120034274
2012-02-09

PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS

#708
20120029073
2012-02-02

Pharmaceutical compositions having desirable bioavailability

#709
20120029072
2012-02-02

Pleuromutilin derivatives for the treatment of diseases mediated by microbes

#710
20110319454
2011-12-29

Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity

#711
20110306664
2011-12-15

MEDICAL DIETARY COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES

#712
20110306663
2011-12-15

TRIHEPTANOIN DIET FOR ADULT POLYGLUCOSAN BODY DISEASE (APBD) TREATMENT

#713
20110305731
2011-12-15

PHARMACEUTICAL FORMULATION BETWEEN JASMONATES AND IT DERIVATIVES AND NANOCARRIES OR MICROCARRIES

#714
20110294891
2011-12-01

METHODS AND COMPOSITIONS FOR TREATING OPTHALMIC CONDITIONS WITH RETINOL DERIVATIVES

#715
20110288170
2011-11-24

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#716
20110281853
2011-11-17

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION

#717
20110280931
2011-11-17

MATRIX METALLOPROTEINASE INHIBITOR

#718
20110280813
2011-11-17

NEURAMINIDASE INHIBITORS AND USES THEREOF

#719
20110276131
2011-11-10

Nasolacrimal drainage system implants for drug therapy

#720
20110275718
2011-11-10

Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same

#721
20110275584
2011-11-10

PREVENTION AND TREATMENT OF INFLAMMATION-INDUCED AND/OR IMMUNE-MEDIATED BONE LOSS

#722
20110269835
2011-11-03

Female Sex Pheromone of the Dogwood Borer (DWB), Synanthedon scitula, and Attraction Inhibitor (Antagonist)

#723
20110257266
2011-10-20

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

#724
20110250142
2011-10-13

COMBINATION THERAPIES FOR TREATMENT OF HYPERTENSION AND COMPLICATIONS IN PATIENTS WITH DIABETES OR METABOLIC SYNDROME

#725
20110245294
2011-10-06

METHODS OF IMPROVING QUALITY OF SLEEP

#726
20110243917
2011-10-06

Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient

#727
20110229437
2011-09-22

Method of Treating Asthma with Antiviral Agents

#728
20110218204
2011-09-08

Pharmaceutically acceptable salts of betulinic acid derivatives

#729
20110218180
2011-09-08

Esters of capsaicin for treating pain

#730
20110213026
2011-09-01

EXTRACTS WITH LIVER-X-RECEPTOR MODULATORS, COMPOUNDS AND THEIR USE ESPECIALLY IN WEIGHT CONTROL

#731
20110206764
2011-08-25

Formulations for enhanced bioavailability of orally administered polar agents

#732
20110206638
2011-08-25

COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES

#733
20110201665
2011-08-18

Compositions, Methods, and Kits for Treating Influenza Viral Infections

#734
20110196031
2011-08-11

Compositions and methods for treating varicose veins

#735
20110190388
2011-08-04

Ursolic acid derivative and pharmaceutical composition thereof

#736
20110189212
2011-08-04

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#737
20110184034
2011-07-28

Severe sepsis preventive therapeutic agent

#738
20110182964
2011-07-28

Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease

#739
20110151028
2011-06-23

Topical vaginal preparation

#740
20110151024
2011-06-23

Compositions and Methods for Preventing Migraines

#741
20110124725
2011-05-26

Treatment for meibomian gland dysfunction or obstruction

#742
20110117218
2011-05-19

Composition and uses for influencing hair growth

#743
20110105432
2011-05-05

Aminocarboxylic acid derivative and medicinal use thereof

#744
20110104297
2011-05-05

Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

#745
20110098349
2011-04-28

CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS

#746
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#747
20110091488
2011-04-21

Water-swellable polymers

#748
20110071176
2011-03-24

PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME

#749
20110065790
2011-03-17

Latanoprost-containing aqueous pharmaceutical composition

#750
20110052740
2011-03-03

Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent

#751
20110046221
2011-02-24

THERAPEUTIC INTERVENTION TO MIMIC THE EFFECT OF CALORIC RESTRICTION

#752
20110046091
2011-02-24

COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT

#753
20110039922
2011-02-17

18β-glycyrrhetinic acid derivatives and synthetic method thereof

#754
20110039903
2011-02-17

Acute Pharmacologic Augmentation of Psychotherapy with Enhancers of Learning or Conditioning

#755
20110034554
2011-02-10

Compositions and methods for treating macular degeneration

#756
20110028510
2011-02-03

Compositions, Methods, and Kits for Treating Influenza Viral Infections

#757
20110027223
2011-02-03

Use of electrophilic compounds for inducing platelet production or maintaining platelet function

#758
20110021526
2011-01-27

Pharmaceutical composition for treatment of diabetic complications

#759
20110015186
2011-01-20

Methods and compositions for protecting and treating neuroinjury

#760
20100331404
2010-12-30

Vector delivery-based microbicides

#761
20100330173
2010-12-30

Compounds and methods for treating influenza

#762
20100323978
2010-12-23

Non-aqueous oil delivery system for ophthalmic drugs

#763
20100311780
2010-12-09

Nitric oxide amino acid ester compound, composition for increasing nitric oxide levels and method of use

#764
20100298443
2010-11-25

Methods and compositions for treating ophthalmic conditions with retinyl derivatives

#765
20100297033
2010-11-25

Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease

#766
20100292325
2010-11-18

P-MENTHAWE-3-CARBOXYLIC ACID ESTERS TO TREAT AIRWAYS DISEASES

#767
20100284994
2010-11-11

Use of EDTA and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases

#768
20100282622
2010-11-11

Solid formulations of prostacyclin analogs

#769
20100280128
2010-11-04

Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain

#770
20100280113
2010-11-04

2,2-dimethylbutyric acid oral pharmaceutical compositions

#771
20100272710
2010-10-28

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AGING-ASSOCIATED DISEASES

#772
20100267807
2010-10-21

Alleviating neuropathic pain with EETs and sEH inhibitors

#773
20100256239
2010-10-07

Anthracenedione compounds

#774
20100234416
2010-09-16

Use of huperzine for disorders

#775
20100227001
2010-09-09

METHOD OF DELIVERING NUTRIENTS

#776
20100222427
2010-09-02

Pharmaceutical composition comprising oseltamivir phosphate

#777
20100216876
2010-08-26

ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA

#778
20100197778
2010-08-05

PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES

#779
20100179218
2010-07-15

OCULOSELECTIVE DRUGS AND PRODRUGS

#780
20100160433
2010-06-24

Treatment of neurodegenerative and cardiovascular disorders

#781
20100158996
2010-06-24

ESTER COMPOUND AND MEDICAL USE THEREOF

#782
20100144875
2010-06-10

Compositions and Methods for Preserving Brain Function

#783
20100130606
2010-05-27

Pharmaceutical compositions comprising fesoterodine

#784
20100125103
2010-05-20

COMPOSITION FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME CONTAINING OBOVATOL AND ITS SYNTHESIZED DERIVATIVES

#785
20100120908
2010-05-13

EYE DROP PREPARATION COMPRISING LATANOPROST

#786
20100120720
2010-05-13

HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells

#787
20100119608
2010-05-13

Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles

#788
20100119595
2010-05-13

Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents

#789
20100099771
2010-04-22

USE OF COOLING AGENTS TO RELIEVE MILD OCULAR IRRITATION AND ENHANCE COMFORT

#790
20100099668
2010-04-22

Local topical administration formulations containing indoxacarb

#791
20100093855
2010-04-15

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#792
20100093853
2010-04-15

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

#793
20100087523
2010-04-08

Rupestonic acid derivatives and use thereof

#794
20100087447
2010-04-08

Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination

#795
20100087413
2010-04-08

Prevention and treatment of inflammation-induced and/or immune-mediated bone loss

#796
20100081713
2010-04-01

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#797
20100076043
2010-03-25

Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use

#798
20100068314
2010-03-18

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#799
20100056626
2010-03-04

COSMETIC PRODUCT FOR THE TREATMENT OF CICATRICIAL TISSUES

#800
20100056621
2010-03-04

Agonists of a bitter taste receptor and uses thereof

#801
20100055055
2010-03-04

Topical formulations of tellurium-containing compounds

#802
20100048545
2010-02-25

Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity

#803
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#804
20100035987
2010-02-11

Pleuromutilin derivatives for the treatment of diseases mediated by microbes

#805
20100035986
2010-02-11

Methods for the treatment and prevention of age-related retinal dysfunction

#806
20100034768
2010-02-11

COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES

#807
20100029770
2010-02-04

Methods of treating fragile X syndrome and autism

#808
20100015147
2010-01-21

Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside

#809
20100010084
2010-01-14

High penetration prodrug compositions of retinoids and retinoid-related compounds

#810
20100010079
2010-01-14

Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases

#811
20090326037
2009-12-31

Medicinal Agent For Treating Viral Infections

#812
20090311188
2009-12-17

In vivo methods of identifying compounds which target suppressed cancer cells

#813
20090304790
2009-12-10

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#814
20090298936
2009-12-03

METHOD FOR ENERGIZING HUMAN BEINGS

#815
20090292017
2009-11-26

Therapeutic compositions

#816
20090275554
2009-11-05

Aminocarboxylic acid derivative and medicinal use thereof

#817
20090247521
2009-10-01

SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION

#818
20090234013
2009-09-17

Pharmaceutical compositions having desirable bioavailability

#819
20090234004
2009-09-17

PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY

#820
20090233882
2009-09-17

Methods and Compositions for the Treatment of Gastrointestinal Disorders

#821
20090232763
2009-09-17

AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES

#822
20090220598
2009-09-03

Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists

#823
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#824
20090197951
2009-08-06

Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death

#825
20090192223
2009-07-30

GIP SECRETION INHIBITOR

#826
20090176877
2009-07-09

Oseltamivir phosphate granule and preparation method thereof

#827
20090170939
2009-07-02

Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy

#828
20090170931
2009-07-02

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

#829
20090143350
2009-06-04

Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods

#830
20090118366
2009-05-07

ORGANIC COMPOUNDS

#831
20090117159
2009-05-07

Pharmaceutical compositions comprising fesoterodine

#832
20090110755
2009-04-30

Compositions and Methods for Preventing Migraines

#833
20090105314
2009-04-23

Pharmaceutical Agent

#834
20090098221
2009-04-16

Creatine ascorbyl derivatives and methods of use thereof

#835
20090092656
2009-04-09

Method of treating atrophic vaginitis

#836
20090092654
2009-04-09

Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System

#837
20090088474
2009-04-02

Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

#838
20090088373
2009-04-02

USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE

#839
20090082371
2009-03-26

Treatment of Viral Disease and Cancer With Nf-kappaB Inhibitors

#840
20090076143
2009-03-19

Compositions and methods for treating inflammation and inflammation-related disorders by extracts

#841
20090054532
2009-02-26

Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation

#842
20090042823
2009-02-12

USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA

#843
20090036819
2009-02-05

Drug eluting ocular implant with anchor and methods thereof

#844
20090036457
2009-02-05

Utilities of olefin derivatives

#845
20090035379
2009-02-05

Fenofibrate compositions

#846
20090012161
2009-01-08

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#847
20090011059
2009-01-08

Ginger Extract For Inhibiting Human Drug Transporters

#848
20090005339
2009-01-01

Methods of treating ear infections

#849
20080312583
2008-12-18

TOPICAL COMPOSITION FOR TREATING PAIN

#850
20080311218
2008-12-18

TOPICAL COMPOSITION FOR TREATING PAIN

#851
20080311217
2008-12-18

TOPICIAL COMPOSITION FOR TREATING PAIN

#852
20080311167
2008-12-18

Topical composition for treating pain

#853
20080306157
2008-12-11

Therapeutic intervention to MIMIC the effect of caloric restriction

#854
20080306143
2008-12-11

Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders

#855
20080300261
2008-12-04

Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease

#856
20080300217
2008-12-04

Combination Therapy with Fumaric Acid Esters for the Treatment of Autoimmune and/or Inflammatory Disorders

#857
20080300205
2008-12-04

Epigenetic mechanisms re-establish access to long-term memory after neuronal loss

#858
20080299196
2008-12-04

Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester

#859
20080293814
2008-11-27

CONCENTRATE ESMOLOL

#860
20080290328
2008-11-27

Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog

#861
20080287377
2008-11-20

Composition Based on Triethyl Citrate for the Prevention of Enzymatic Hydrolysis of Triglycerides

#862
20080275125
2008-11-06

Combination Composition

#863
20080274203
2008-11-06

Bioeffective krill oil compositions

#864
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#865
20080254010
2008-10-16

Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract

#866
20080242674
2008-10-02

Medicine For Prevention or Treatment of Frequent Urination or Urinary Incontinence

#867
20080233559
2008-09-25

Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein

#868
20080226746
2008-09-18

Nutritional supplement for women

#869
20080221208
2008-09-11

Retinal derivatives and methods for the use thereof for the treatment of visual disorders

#870
20080206162
2008-08-28

Composition and methods for treating Alzheimer's disease and other amyloidoses

#871
20080200550
2008-08-21

Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein

#872
20080200549
2008-08-21

PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND PARACETAMOL AND METHODS OF USING THE SAME

#873
20080188475
2008-08-07

Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators

#874
20080182900
2008-07-31

Method of treatment of virus infections using shikonin compounds

#875
20080175800
2008-07-24

USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES

#876
20080171788
2008-07-17

Medicament For Irritable Bowel Syndrome

#877
20080171766
2008-07-17

Novel Method

#878
20080159961
2008-07-03

Pharmaceutical Composition

#879
20080153791
2008-06-26

11Beta -Hydroxysteroid Dehydrogenases

#880
20080145446
2008-06-19

Multi-purpose hand and/or skin cleaner, sanitizer, drug delivery and exercise system

#881
20080138421
2008-06-12

Pharmaceutical compositions comprising fesoterodine

#882
20080103328
2008-05-01

Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators

#883
20080090825
2008-04-17

Metallo-β-lactamase inhibitors

#884
20080075793
2008-03-27

ANTIVIRAL COMPOSITIONS AND METHODS OF USE

#885
20080069855
2008-03-20

METHOD OF INHIBITING THE FORMATION OF ADHESIONS AND SCAR TISSUE AND REDUCING BLOOD LOSS

#886
20080064759
2008-03-13

Process for preparing fenofibrate compositions

#887
20080064723
2008-03-13

Anti-Hair Graying Agent

#888
20080064660
2008-03-13

Modulation of Inflammation Related to Columnar Epithelia

#889
20080063730
2008-03-13

Methods for prophylactic and therapeutic nutritional supplementation

#890
20080063726
2008-03-13

Fenofibrate compositions

#891
20080058413
2008-03-06

Derivatives of sandalwood oil and santalols for treating cold sores and herpes

#892
20080045590
2008-02-21

USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME

#893
20080033041
2008-02-07

USE OF PHENYLETHANOLAMINOTETRALINES FOR PREPARING ANXIOLYTIC DRUGS

#894
20080027136
2008-01-31

Compositions and methods for the treatment of cystic fibrosis

#895
20080027030
2008-01-31

Pharmaceutical compositions comprising amifostine and related compounds

#896
20080026035
2008-01-31

Method of treating atrophic vaginitis

#897
20080021262
2008-01-24

Process for Effecting the Relaxation of Muscles of a Human by Means of Fragrance

#898
20080020996
2008-01-24

Esters of capsaicin for treating pain

#899
20070270490
2007-11-22

USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA

#900
20070269487
2007-11-22

Drug delivery methods, structures, and compositions for nasolacrimal system